Question follow-through · 51362

Cystic Fibrosis: Pancreatic Enzyme Replacement Therapy

To ask the Secretary of State for Health and Social Care, what steps he is taking to protect patients with cystic fibrosis in the context of a shortage of Creon gastro-resistant capsules.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body: Department of Health and Social Care
Tabled: 12 May 2025
Target answer date: 14 May 2025
Answer: 15 May 2025 · 3 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
Health Bill: Report Stage: New Clause 143 · 8 Sept 2026

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

12 May 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what steps he is taking to protect patients with cystic fibrosis in the context of a shortage of Creon gastro-resistant capsules.
14 May 2025
Target answer date
Date supplied by the official written-questions record.
15 May 2025
Answer published
The Department is in regular discussions with the supplier of Creon on the latest stock availability and the actions that are being taken to mitigate the supply issue that is affecting the whole of the United Kingdom. Through these discussions we have man...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.